Evaluation of the effect of omega 3 fatty acid in patients with hashimoto thyroiditis
Phase 2
- Conditions
- hashimoto disease.Autoimmune thyroiditis
- Registration Number
- IRCT2017050629508N6
- Lead Sponsor
- by my own
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Hashimoto patients over 18 years. Exclusion criteria: patients with rheumatoid arthritis; celiac disease; pernicious anemia; Systematic lupus erythematous and other autoimmune disease and other acute or chronic infections disease; postmenopausal women; pregnant and lactating women; taking drugs such as warfarin; aspirin; gamma interferon; smoking; using contraceptive drugs; Seasonal allergies; allergy to the fish or oil fish; eating fish over twice in week.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TNF-a (tumor necrosis factor alpha). Timepoint: before and 8 week after intervention. Method of measurement: laboratory kit.;ESR (erythrocyte sedimentation rate). Timepoint: before and 8 week after intervention. Method of measurement: laboratory kit.;Hs_CRP (high-sensitivity C-reactive protein). Timepoint: before and 8 week after intervention. Method of measurement: laboratory kit.
- Secondary Outcome Measures
Name Time Method 24 hour recall. Timepoint: before and 8 week after intervention. Method of measurement: 24 hour recall questioniare.